Argos Therapeutics Announces US and Global Expansion for Ongoing Pivotal Phase 3 ADAPT Study for Personalized Immunotherapy
June 10, 2013 11:03 ET
|
Argos Therapeutics
DURHAM, N.C., June 10, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the...
Inc. Magazine Launches a Redesign That Thoroughly Transforms Its Look and Structure
June 03, 2013 14:46 ET
|
Inc.
New York, June 3, 2013 (GLOBE NEWSWIRE) -- The oldest and most trusted publication aimed at entrepreneurs
has been redesigned and restructured to meet the changing habits of
readers, more closely...
Argos Therapeutics to Present at the Sachs Cancer Bio Partnering Forum
May 20, 2013 08:05 ET
|
Argos Therapeutics
DURHAM, N.C., May 20, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the...
Argos Therapeutics to Present at the 12th Annual Needham Healthcare Conference
April 29, 2013 09:01 ET
|
Argos Therapeutics
DURHAM, N.C., April 29, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the...
Argos Therapeutics Welcomes Jean Lamarre to Board of Directors
March 13, 2013 09:30 ET
|
Argos Therapeutics
DURHAM, N.C., March 13, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the...
Inc. and The Small Giants Community Announce A Dynamic Partnership
March 06, 2013 10:31 ET
|
Inc.
New York, March 6, 2013 (GLOBE NEWSWIRE) -- Inc. (www.inc.com) and the Small Giants Community
(www.smallgiants.org) are excited to announce a
working partnership geared toward building a community of...
Argos Therapeutics Validates Durability of AGS-003 Induced Immune Response in mRCC Patients
March 04, 2013 08:01 ET
|
Argos Therapeutics
DURHAM, N.C., March 4, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the...
Argos Therapeutics Announces Updated Phase 2 Data for AGS-003 Personalized Immunotherapy for Metastatic Renal Cell Carcinoma
February 14, 2013 08:01 ET
|
Argos Therapeutics
DURHAM, N.C., Feb. 14, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the...
Inc. Magazine now accepting applications for the 2013 Inc.500|5000, America's most prestigious ranking of fast-growing private companies.
February 07, 2013 14:15 ET
|
Inc.
New York, Feb. 7, 2013 (GLOBE NEWSWIRE) -- Inc. magazine, the only major business magazine
created solely for CEOs of fast-growing, private companies, is now
accepting applications for the Inc....
Sir Richard Branson to Keynote Inc.'s 2013 GROWCO
January 28, 2013 15:32 ET
|
Inc.
New York City, Jan. 28, 2013 (GLOBE NEWSWIRE) -- Inc. magazine is thrilled to announce Sir Richard
Branson will deliver the opening keynote at the Grow Your Company Conference
(GROWCO)Wednesday, April...